Document ID: chunk:federal_register_of_legislation:F2024L01389:schedule:1:p7
Version: federal_register_of_legislation:F2024L01389
Segment Type: schedule
Provision Reference: sch 1 (pt 7/66)
Character Range: 18153–21192

omit from the column headed "Purposes": P14308 substitute: P14301
[52] Schedule 1, Part 1, entry for Dabigatran etexilate in the form Capsule 150 mg (as mesilate) [Brand: ARX-Dabigatran; Maximum Quantity: 120; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14308  substitute: C14301
(b) omit from the column headed "Purposes": P14308 substitute: P14301
[53] Schedule 1, Part 1, entry for Dabigatran etexilate in the form Capsule 150 mg (as mesilate) [Brand: Dabigatran Sandoz; Maximum Quantity: 120; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14308  substitute: C14301
(b) omit from the column headed "Purposes": P14308 substitute: P14301
[54] Schedule 1, Part 1, entry for Dabigatran etexilate in the form Capsule 150 mg (as mesilate) [Brand: PHARMACOR DABIGATRAN; Maximum Quantity: 120; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14308  substitute: C14301
(b) omit from the column headed "Purposes": P14308 substitute: P14301
[55] Schedule 1, Part 1, entry for Dabigatran etexilate in the form Capsule 150 mg (as mesilate) [Brand: Pradaxa; Maximum Quantity: 120; Number of Repeats: 5]
(a) omit from the column headed "Circumstances": C14308  substitute: C14301
(b) omit from the column headed "Purposes": P14308 substitute: P14301
[56] Schedule 1, Part 1, after entry for Dapagliflozin with metformin in the form Tablet (modified release) containing 10 mg dapagliflozin (as propanediol monohydrate) with 500 mg metformin hydrochloride [Maximum Quantity: 56; Number of Repeats: 5]
insert:
Dapagliflozin with sitagliptin  Tablet containing 10 mg dapagliflozin (as propanediol monohydrate) with 100 mg sitagliptin (as phosphate monohydrate)  Oral  Sidapvia 10/100  AP  MP NP  C15269  P15269  28  5     28
Dapagliflozin with sitagliptin  Tablet containing 10 mg dapagliflozin (as propanediol monohydrate) with 100 mg sitagliptin (as phosphate monohydrate)  Oral  Sidapvia 10/100  AP  MP NP  C15270  P15270  56  5     28

[57] Schedule 1, Part 1, entry for Diazepam in the form Tablet 2 mg
omit:
Diazepam  Tablet 2 mg  Oral  APO-Diazepam  TX  MP NP PDP            50         0            50
Diazepam  Tablet 2 mg  Oral  APO-Diazepam  TX  MP NP         P6176  50 CN6176  3 CN6176     50

[58] Schedule 1, Part 1, entry for Diazepam in the form Tablet 5 mg
omit:
Diazepam  Tablet 5 mg  Oral  APO-Diazepam  TX  MP NP PDP            50         0            50
Diazepam  Tablet 5 mg  Oral  APO-Diazepam  TX  MP NP         P6176  50 CN6176  3 CN6176     50

[59] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 25 mg
omit:
Diclofenac  Tablet (enteric coated) containing diclofenac sodium 25 mg  Oral  APO-Diclofenac  TX  PDP          100  0     50
Diclofenac  Tablet (enteric coated) containing diclofenac sodium 25 mg  Oral  APO-Diclofenac  TX  MP NP        100  3     50

[60] Schedule 1, Part 1, entry for Diclofenac in the form Tablet (enteric coated) containing diclofenac sodium 50 mg
omit:
Diclofenac